Lastly, follow-up CT scans can help monitor disease progression and recovery.

后续跟进的CT扫描可以帮助监测疾病的进展和恢复情况。

But what can we do to intervene earlier in that disease progression?

在疾病恶化早期我们能做什么干预呢？

For high tau patients, donanemab slowed the disease progression by about 17 percent.

对于tau水平高的患者，多纳单抗将疾病进展减缓了约17%。

The inactive phase occurs when disease progression stops but the tissue damage and symptoms remain.

在非活动期，疾病停止进展，但组织损害和相关体征仍然存在。

In fact, even heterozygous mutations which lead to fewer co-receptors on the cells, can make it harder for the virus to spread, and results in a slower disease progression.

事实上，即使是导致辅助受体数量减少的杂合变异，也会阻碍病毒传播，减缓疾病进程。